Home
Conditions
Paraganglioma

Clinical trial condition

Paraganglioma

Explore clinical trials studying Paraganglioma. Study availability and eligibility vary by location and protocol.

70 public trials 27 recruiting studies

Refine in advanced search Browse all conditions

Paraganglioma trial results

Not Yet Recruiting

Zanzalintinib in Unresectable and Progressive MPGGs

NCT07714551

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: Brigham and Women's Hospital (BWH) Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)

NCT07538791

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Policlinico di Bari Bari, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

Azienda Ospedaliero-Universitaria di Ferrara Ferrara, Italy

Irst Irccs Meldola, Italy

View Trial Details

Not Yet Recruiting

211At-MABG in Adults With Advanced Neuroendocrine Cancers

NCT07661420

Conditions: Adenocarcinoma, Bronchial Carcinoid, Carcinoma, +14 more
Locations: University of Pennsylvania - Abramson Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Not Yet Recruiting

A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies

NCT07621146

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
Locations: BC Cancer Vancouver Vancouver, British Columbia, Canada

View Trial Details

Not Yet Recruiting

Prospective Cohort Study of Pheochromocytoma/Paraganglioma

NCT07516275

Conditions: Hemodynamic Instability, Intraoperative Complications, Neoplasms, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study

NCT04788927

Conditions: Disease Attributes, Disease Susceptibility, Genetic Predisposition to Disease, +15 more
Locations: Rigshospitalet Copenhagen, Denmark

National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark

View Trial Details

Completed

Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma

NCT04573816

Conditions: Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Hopital européen Georges Pompidou Paris, France

View Trial Details

Completed

Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)

NCT07412158

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Department of Urology, Peking University First Hospital, Beijing, 100034 Beijing, China

View Trial Details

Completed

Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma

NCT01022515

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +9 more
Locations: CIC 9301 Lille, France

Endocrinology Department Lille, France

Inserm U982/EA 4310; Rouen University (DC2N) Mont-Saint-Aignan, France

Cardiology Department Paris, France

View Trial Details

Completed

Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery

NCT02302833

Conditions: Locally Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Paraganglioma, +11 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Paraganglioma

Paraganglioma trial results

Related conditions